Loading...
•
Sep 30, 2020
ICU Medical Q3 2020 Earnings Report
Announced third quarter 2020 results and updated fiscal year 2020 guidance.
Key Takeaways
ICU Medical, Inc. reported third quarter revenue of $318.6 million, compared to $307.5 million in the same period last year. GAAP net income for the third quarter of 2020 was $25.0 million, or $1.16 per diluted share, as compared to GAAP net income of $26.6 million, or $1.24 per diluted share, for the third quarter of 2019.
Third quarter revenue was $318.6 million, compared to $307.5 million in the same period last year.
GAAP gross profit for the third quarter of 2020 was $113.9 million, as compared to $118.6 million in the same period last year.
GAAP gross margin for the third quarter of 2020 was 36%, as compared to 39% in the same period last year.
Adjusted diluted earnings per share for the third quarter of 2020 were $1.90 as compared to $1.65 for the third quarter of 2019.
Revenue by Segment
Forward Guidance
The Company is narrowing its 2020 outlook for adjusted EBITDA from a range of $230 million to $250 million to a range of $235 million to $245 million and updating adjusted earnings per share from a range of $5.95 to $6.65 to a range of $6.65 to $7.00.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...